Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0000902664-19-004510
Filing Date
2019-12-06
Accepted
2019-12-06 08:04:33
Documents
2
Effectiveness Date
2019-12-06

Document Format Files

Seq Description Document Type Size
1 ENZO BIOCHEM INC p19-2312defc14a.htm DEFC14A 214337
2 GRAPHIC image_002.jpg GRAPHIC 19972
  Complete submission text file 0000902664-19-004510.txt   243697
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: DEFC14A | Act: 34 | File No.: 001-09974 | Film No.: 191271735
SIC: 8071 Services-Medical Laboratories

Mailing Address HARBERT DISCOVERY FUND GP, LLC 2100 THIRD AVENUE NORTH, SUITE 600 BIRMINGHAM AL 35203
Business Address HARBERT DISCOVERY FUND GP, LLC 2100 THIRD AVENUE NORTH, SUITE 600 BIRMINGHAM AL 35203 205-987-5500
Harbert Discovery Fund, LP (Filed by) CIK: 0001626127 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A